Insider Transactions in Q3 2023 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 01
2023
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,500
-4.89%
|
$216,000
$144.25 P/Share
|
Aug 29
2023
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
142
-2.32%
|
$20,306
$143.47 P/Share
|
Aug 15
2023
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
750
-2.39%
|
$104,250
$139.59 P/Share
|
Aug 14
2023
|
Anne O Riordan Director |
SELL
Open market or private sale
|
Direct |
1,241
-9.0%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
1,241
-4.78%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Rick E Winningham Director |
SELL
Open market or private sale
|
Direct |
1,241
-10.62%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
1,241
-14.52%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Catherine A. Sohn Director |
SELL
Open market or private sale
|
Direct |
1,241
-7.7%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Norbert G Riedel Director |
SELL
Open market or private sale
|
Direct |
1,241
-8.3%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Heather Ann Mc Sharry Director |
SELL
Open market or private sale
|
Direct |
1,344
-7.42%
|
$185,472
$138.16 P/Share
|
Aug 14
2023
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
1,241
-5.59%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Peter Gray Director |
SELL
Open market or private sale
|
Direct |
1,241
-7.17%
|
$171,258
$138.16 P/Share
|
Aug 14
2023
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
158
-2.51%
|
$21,804
$138.16 P/Share
|
Aug 14
2023
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
1,241
-14.52%
|
$171,258
$138.16 P/Share
|
Aug 11
2023
|
Anne O Riordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+18.23%
|
-
|
Aug 11
2023
|
Kenneth W O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+10.59%
|
-
|
Aug 11
2023
|
Rick E Winningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+20.83%
|
-
|
Aug 11
2023
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+26.46%
|
-
|
Aug 11
2023
|
Catherine A. Sohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+16.03%
|
-
|
Aug 11
2023
|
Seamus Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+0.26%
|
-
|
Aug 11
2023
|
Norbert G Riedel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+17.06%
|
-
|
Aug 11
2023
|
Mary Elizabeth Henderson SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,763
+50.0%
|
-
|
Aug 11
2023
|
Heather Ann Mc Sharry Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+14.51%
|
-
|
Aug 11
2023
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+12.17%
|
-
|
Aug 11
2023
|
Peter Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+15.09%
|
-
|
Aug 11
2023
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,075
+26.46%
|
-
|
Aug 07
2023
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,390
-4.23%
|
$182,090
$131.51 P/Share
|